Which has stronger valuation & earnings, CI or GH?

Cigna Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cigna Group $281.34B 0.26 $5.96B $24.17 11.43 Guardant Health $982.02M 23.33 -$416.28M -$3.49 N/A

Does the media refer more to CI or GH?

In the previous week, Cigna Group had 24 more articles in the media than Guardant Health. MarketBeat recorded 37 mentions for Cigna Group and 13 mentions for Guardant Health. Cigna Group's average media sentiment score of 1.47 beat Guardant Health's score of 1.40 indicating that Cigna Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cigna Group 31 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 12 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor GH or DGX?

In the previous week, Quest Diagnostics had 17 more articles in the media than Guardant Health. MarketBeat recorded 30 mentions for Quest Diagnostics and 13 mentions for Guardant Health. Guardant Health's average media sentiment score of 1.40 beat Quest Diagnostics' score of 1.38 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 12 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quest Diagnostics 27 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, GH or LH?

Labcorp has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $982.02M 23.33 -$416.28M -$3.49 N/A Labcorp $14.35B 1.90 $876.50M $12.09 27.79

Does the media favor GH or LH?

In the previous week, Guardant Health had 4 more articles in the media than Labcorp. MarketBeat recorded 13 mentions for Guardant Health and 9 mentions for Labcorp. Guardant Health's average media sentiment score of 1.40 beat Labcorp's score of 0.78 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 12 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Labcorp 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer FMS or GH?

In the previous week, Guardant Health had 11 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 13 mentions for Guardant Health and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Guardant Health's average media sentiment score of 1.40 beat Fresenius Medical Care AG & Co. KGaA's score of 1.27 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 12 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor GH or BTSG?

In the previous week, Guardant Health had 5 more articles in the media than BrightSpring Health Services. MarketBeat recorded 13 mentions for Guardant Health and 8 mentions for BrightSpring Health Services. Guardant Health's average media sentiment score of 1.40 beat BrightSpring Health Services' score of 1.11 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 12 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BrightSpring Health Services 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Guardant Health (GH) Competitors

$170.69 +2.81 (+1.67%)

As of 08/21/2026 04:00 PM Eastern

Compare

GH vs. CI, DGX, LH, FMS, and BTSG

Should you buy Guardant Health stock or one of its competitors? Guardant Health's main competitors and comparable companies include Cigna Group (CI), Quest Diagnostics (DGX), Labcorp (LH), Fresenius Medical Care AG & Co. KGaA (FMS), and BrightSpring Health Services (BTSG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Guardant Health compare to Cigna Group?

Cigna Group (NYSE:CI) and Guardant Health (NASDAQ:GH) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership and valuation.

In the previous week, Cigna Group had 24 more articles in the media than Guardant Health. MarketBeat recorded 37 mentions for Cigna Group and 13 mentions for Guardant Health. Cigna Group's average media sentiment score of 1.47 beat Guardant Health's score of 1.40 indicating that Cigna Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cigna Group	31 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardant Health	12 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cigna Group presently has a consensus target price of $339.45, indicating a potential upside of 22.90%. Guardant Health has a consensus target price of $183.78, indicating a potential upside of 7.67%. Given Cigna Group's higher possible upside, research analysts plainly believe Cigna Group is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cigna Group	0 Sell rating(s)	7 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.68
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96

87.0% of Cigna Group shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 0.6% of Cigna Group shares are held by insiders. Comparatively, 5.6% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Cigna Group has a beta of 0.29, indicating that its share price is 71% less volatile than the broader market. Comparatively, Guardant Health has a beta of 1.6, indicating that its share price is 60% more volatile than the broader market.

Cigna Group has a net margin of 2.27% compared to Guardant Health's net margin of -38.33%. Cigna Group's return on equity of 19.75% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cigna Group	2.27%	19.75%	5.34%
Guardant Health	-38.33%	N/A	-25.40%

Cigna Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cigna Group	$281.34B	0.26	$5.96B	$24.17	11.43
Guardant Health	$982.02M	23.33	-$416.28M	-$3.49	N/A

Summary

Cigna Group beats Guardant Health on 10 of the 17 factors compared between the two stocks.

How does Guardant Health compare to Quest Diagnostics?

Guardant Health (NASDAQ:GH) and Quest Diagnostics (NYSE:DGX) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk.

Quest Diagnostics has a net margin of 9.18% compared to Guardant Health's net margin of -38.33%. Quest Diagnostics' return on equity of 16.01% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
Quest Diagnostics	9.18%	16.01%	7.27%

Guardant Health presently has a consensus price target of $183.78, suggesting a potential upside of 7.67%. Quest Diagnostics has a consensus price target of $235.31, suggesting a potential downside of 3.70%. Given Guardant Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe Guardant Health is more favorable than Quest Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54

In the previous week, Quest Diagnostics had 17 more articles in the media than Guardant Health. MarketBeat recorded 30 mentions for Quest Diagnostics and 13 mentions for Guardant Health. Guardant Health's average media sentiment score of 1.40 beat Quest Diagnostics' score of 1.38 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	12 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Quest Diagnostics	27 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by insiders. Comparatively, 0.9% of Quest Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Guardant Health has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market. Comparatively, Quest Diagnostics has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market.

Quest Diagnostics has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	23.33	-$416.28M	-$3.49	N/A
Quest Diagnostics	$11.04B	2.44	$992M	$9.42	25.94

Summary

Guardant Health and Quest Diagnostics tied by winning 8 of the 16 factors compared between the two stocks.

How does Guardant Health compare to Labcorp?

Guardant Health (NASDAQ:GH) and Labcorp (NYSE:LH) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability, media sentiment and institutional ownership.

Labcorp has a net margin of 6.99% compared to Guardant Health's net margin of -38.33%. Labcorp's return on equity of 16.74% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
Labcorp	6.99%	16.74%	7.81%

Guardant Health currently has a consensus target price of $183.78, indicating a potential upside of 7.67%. Labcorp has a consensus target price of $330.00, indicating a potential downside of 1.79%. Given Guardant Health's stronger consensus rating and higher probable upside, research analysts plainly believe Guardant Health is more favorable than Labcorp.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Labcorp	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75

In the previous week, Guardant Health had 4 more articles in the media than Labcorp. MarketBeat recorded 13 mentions for Guardant Health and 9 mentions for Labcorp. Guardant Health's average media sentiment score of 1.40 beat Labcorp's score of 0.78 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	12 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Labcorp	5 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Labcorp has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	23.33	-$416.28M	-$3.49	N/A
Labcorp	$14.35B	1.90	$876.50M	$12.09	27.79

Guardant Health has a beta of 1.6, meaning that its share price is 60% more volatile than the broader market. Comparatively, Labcorp has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market.

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 95.9% of Labcorp shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Comparatively, 0.8% of Labcorp shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Guardant Health beats Labcorp on 9 of the 17 factors compared between the two stocks.

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Guardant Health (NASDAQ:GH) are both large-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, valuation, institutional ownership and dividends.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 5.6% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market. Comparatively, Guardant Health has a beta of 1.6, indicating that its stock price is 60% more volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Guardant Health's net margin of -38.33%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%
Guardant Health	-38.33%	N/A	-25.40%

In the previous week, Guardant Health had 11 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 13 mentions for Guardant Health and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Guardant Health's average media sentiment score of 1.40 beat Fresenius Medical Care AG & Co. KGaA's score of 1.27 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardant Health	12 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $23.57, indicating a potential upside of 0.58%. Guardant Health has a consensus price target of $183.78, indicating a potential upside of 7.67%. Given Guardant Health's stronger consensus rating and higher possible upside, analysts plainly believe Guardant Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$19.43B	0.65	$1.11B	$1.93	12.14
Guardant Health	$982.02M	23.33	-$416.28M	-$3.49	N/A

Summary

Guardant Health beats Fresenius Medical Care AG & Co. KGaA on 10 of the 17 factors compared between the two stocks.

How does Guardant Health compare to BrightSpring Health Services?

Guardant Health (NASDAQ:GH) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

Guardant Health has a beta of 1.6, indicating that its share price is 60% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.88, indicating that its share price is 88% more volatile than the broader market.

92.6% of Guardant Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Guardant Health had 5 more articles in the media than BrightSpring Health Services. MarketBeat recorded 13 mentions for Guardant Health and 8 mentions for BrightSpring Health Services. Guardant Health's average media sentiment score of 1.40 beat BrightSpring Health Services' score of 1.11 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	12 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BrightSpring Health Services	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Guardant Health presently has a consensus price target of $183.78, suggesting a potential upside of 7.67%. BrightSpring Health Services has a consensus price target of $70.71, suggesting a potential upside of 20.11%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, analysts clearly believe BrightSpring Health Services is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10

BrightSpring Health Services has a net margin of 2.55% compared to Guardant Health's net margin of -38.33%. BrightSpring Health Services' return on equity of 16.73% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
BrightSpring Health Services	2.55%	16.73%	5.24%

BrightSpring Health Services has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	23.33	-$416.28M	-$3.49	N/A
BrightSpring Health Services	$12.91B	0.90	$190.67M	$1.66	35.46

Summary

BrightSpring Health Services beats Guardant Health on 11 of the 17 factors compared between the two stocks.

Get Guardant Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GH vs. The Competition

Export

Metric	Guardant Health	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$22.91B	$9.83B	$7.36B	$12.84B
Dividend Yield	N/A	2.55%	2.54%	11.08%
P/E Ratio	-48.91	34.38	272.88	24.24
Price / Sales	23.33	4.97	622.17	99.48
Price / Cash	N/A	125.12	78.62	53.99
Price / Book	-102.83	4.05	13.05	6.20
Net Income	-$416.28M	$311.06M	$3.47B	$348.59M
7 Day Performance	8.57%	0.83%	2.09%	0.08%
1 Month Performance	13.64%	2.42%	6.64%	3.88%
1 Year Performance	178.00%	15.69%	25.02%	16.98%

Guardant Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GH Guardant Health	2.8285 of 5 stars	$170.69 +1.7%	$183.78 +7.7%	+178.0%	$22.91B	$982.02M	N/A	2,506	Positive News
CI Cigna Group	4.983 of 5 stars	$275.03 -2.7%	$339.45 +23.4%	-9.2%	$74.66B	$274.90B	11.38	67,700	News Coverage Positive News Insider Trade
DGX Quest Diagnostics	4.2503 of 5 stars	$235.20 +0.3%	$235.31 +0.0%	+35.7%	$25.87B	$11.04B	24.97	57,000	News Coverage Positive News
LH Labcorp	4.2615 of 5 stars	$323.18 +1.6%	$330.00 +2.1%	+20.9%	$25.80B	$13.95B	26.73	71,000	Insider Trade
FMS Fresenius Medical Care AG & Co. KGaA	3.1733 of 5 stars	$23.54 -1.0%	$23.57 +0.1%	-8.4%	$12.77B	$22.20B	12.20	1,488	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GH) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Guardant Health (GH) Competitors

GH vs. CI, DGX, LH, FMS, and BTSG

How does Guardant Health compare to Cigna Group?

Summary

How does Guardant Health compare to Quest Diagnostics?

Summary

How does Guardant Health compare to Labcorp?

Summary

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Guardant Health compare to BrightSpring Health Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GH vs. The Competition

Guardant Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Guardant Health (GH) Competitors

GH vs. CI, DGX, LH, FMS, and BTSG

How does Guardant Health compare to Cigna Group?

Does the media refer more to CI or GH?

Do analysts recommend CI or GH?

Do insiders and institutionals believe in CI or GH?

Which has more risk and volatility, CI or GH?

Is CI or GH more profitable?

Which has stronger valuation & earnings, CI or GH?

Summary

How does Guardant Health compare to Quest Diagnostics?

Is GH or DGX more profitable?

Do analysts prefer GH or DGX?

Does the media favor GH or DGX?

Do institutionals & insiders have more ownership in GH or DGX?

Which has more volatility and risk, GH or DGX?

Which has preferable valuation and earnings, GH or DGX?

Summary

How does Guardant Health compare to Labcorp?

Is GH or LH more profitable?

Do analysts prefer GH or LH?

Does the media favor GH or LH?

Which has better valuation and earnings, GH or LH?

Which has more volatility & risk, GH or LH?

Do insiders and institutionals hold more shares of GH or LH?

Summary

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Do institutionals & insiders believe in FMS or GH?

Which has more risk and volatility, FMS or GH?

Is FMS or GH more profitable?

Does the media prefer FMS or GH?

Do analysts prefer FMS or GH?

Which has stronger valuation & earnings, FMS or GH?

Summary

How does Guardant Health compare to BrightSpring Health Services?

Which has more volatility and risk, GH or BTSG?

Do insiders and institutionals have more ownership in GH or BTSG?

Does the media favor GH or BTSG?

Do analysts recommend GH or BTSG?

Is GH or BTSG more profitable?

Which has preferable earnings and valuation, GH or BTSG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GH vs. The Competition

Guardant Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools